skip to main content

MHRA Message: Moderna COVID-19 Vaccine approval extension – use in children aged 12 to 17 years

Today, MHRA have authorised an extension to the current UK approval of the Spikevax vaccine (formerly COVID-19 Vaccine Moderna) that allows its use in 12 to 17 year-olds. The vaccine is safe and effective in this age group.

read more

Join thousands of public health nurses like you from across the globe.

Become a member of SAPHNA